The global CAR T-cell therapy market is experiencing rapid growth, driven by increasing request for innovative cancer treatments. Future clinical trials have demonstrated the efficacy of CAR T-cell therapy in treating a range of tumors, leading to increasing patient approval. Key trends fueling market growth include advancements in cell engineeri

The global CAR T-cell therapy market is experiencing substantial growth, driven by the increasing prevalence of hematological malignancies, advancements in immunotherapy, and positive regulatory developments. The market is segmented by indication, platform, and geography. Key players in the market include biotechnology companies, research instituti